SINGLE-AGENT LENALIDOMIDE FOR THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE LYMPHOMA PATIENTS

被引：0
|
作者：
Puccini, B. [1 ]
Chitarrelli, I. [1 ]
Antognoli, G. [1 ]
Fabbri, A. [1 ]
Rigacci, L. [1 ]
Lenoci, M. P. [1 ]
Lauria, F. [1 ]
Bosi, A. [1 ]
机构：
[1] Dept Hematol, Florence, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0687
引用
收藏
页码：288 / 288
页数：1
相关论文
共 50 条
  • [21] Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma
    Boell, Boris
    Borchmann, Peter
    Topp, Max S.
    Haenel, Mathias
    Reiners, Katrin S.
    Engert, Andreas
    Naumann, Ralph
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (03) : 480 - 482
  • [22] SALVAGE TREATMENT WITH LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MANTLE CELL LYMPHOMA
    Zaja, F.
    De Luca, S.
    Vitolo, U.
    Orsucci, L.
    Levis, A.
    Salvi, F.
    Gargantini, L.
    Ravelli, E.
    Tucci, A.
    Bottelli, C.
    Balzarotti, M.
    Santoro, A.
    Brusamolino, E.
    Bonfichi, M.
    Di Rocco, A.
    Stelitano, C.
    Baldini, L.
    Pileri, S.
    Volpetti, S.
    Saccona, F.
    Ciccone, G.
    Ferranti, A.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 115 - 115
  • [23] Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison
    Prince, H. Miles
    Adena, Michael
    Smith, Dell Kingsford
    Hertel, Judy
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (02) : 93 - 99
  • [24] Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Wiernik, Peter H.
    Lossos, Izidore S.
    Tuscano, Joseph M.
    Justice, Glen
    Vose, Julie M.
    Cole, Craig E.
    Lam, Wendy
    McBride, Kyle
    Wride, Kenton
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4952 - 4957
  • [25] Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemia
    Buckwalter, M
    Dowell, JA
    Korth-Bradley, J
    Gorovits, B
    Mayer, PR
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (08): : 873 - 880
  • [26] Single-agent Aredia for relapsed/refractory multiple myeloma.
    Berenson, JR
    Webb, IJ
    Anderson, K
    Schlossman, R
    Vescio, R
    Doss, D
    Goon, B
    Swift, R
    VonTeichert, J
    Kowalski, M
    Seaman, J
    BLOOD, 1999, 94 (10) : 307B - 307B
  • [27] Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences
    Eve, Heather E.
    Carey, Sean
    Richardson, Sarah J.
    Heise, Carla C.
    Mamidipudi, Vidya
    Shi, Tao
    Radford, John A.
    Auer, Rebecca L.
    Bullard, Sheila H.
    Rule, Simon A. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (02) : 154 - 163
  • [28] Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.
    Zaja, Francesco
    De Luca, Stefano
    Vitolo, Umberto
    Orsucci, Lorella
    Levis, Alessandro
    Salvi, Flavia
    Gargantini, Livio
    Ravelli, Erika
    Tucci, Alessandra
    Bottelli, Chiara
    Balzarotti, Monica
    Santoro, Armando
    Brusamolino, Ercole
    Bonfichi, Maurizio
    Di Rocco, Alice
    Stelitano, Caterina
    Baldini, Luca
    Pileri, Stefano Aldo
    Volpetti, Stefano
    Ciccone, Giovannino
    Ferranti, Antonella
    Fanin, Renato
    BLOOD, 2009, 114 (22) : 683 - 683
  • [29] Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study
    Goy, Andre
    Sinha, Rajni
    Williams, Michael E.
    Besisik, Sevgi Kalayoglu
    Drach, Johannes
    Ramchandren, Radhakrishnan
    Zhang, Lei
    Cicero, Sherri
    Fu, Tommy
    Witzig, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3688 - +
  • [30] International study of lenalidomide in relapsed/refractory aggressive non-Hodgkin's lymphoma
    Czuczman, M. S.
    Reeder, C. B.
    Polikoff, J.
    Chowhan, N. M.
    Esseessee, I.
    Greenberg, R.
    Ervin-Haynes, A.
    Pietronigro, D.
    Zeldis, J. B.
    Witzig, T. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345